First Hawaiian Bank’s Regenxbio RGNX Stock Holding History

First Hawaiian Bank’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-225	Closed	-$13K	–	1360
2019 Q1	$13K	Buy	+225	New	+$11.1K	﹤0.01%	1317

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Hawaiian Bank's RGNX Position: Q2 2019 in Review

First Hawaiian Bank sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 225 shares — an estimated $13K sold.

First Hawaiian Bank first reported a position in RGNX in Q1 2019 and held it in 1 quarter. The position peaked at $13K in Q1 2019. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

First Hawaiian Bank reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
First Hawaiian Bank sold 225 Regenxbio shares in Q2 2019, an estimated $13K.
First Hawaiian Bank first reported a position in Regenxbio in Q1 2019 and held it in 1 quarter.
First Hawaiian Bank's Regenxbio position peaked at $13K in Q1 2019.
186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.